2019-21311. Bulk Manufacturer of Controlled Substances Application: CreaGen Inc.

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 2, 2019.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on August 14, 2019, CreaGen Inc., 299 Washington Street, Unit A, Woburn, Massachusetts 01801-2795 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substance	Drug code	Schedule
4-Methyl-N-ethylcathinone (4-MEC)	1249	I
Aminorex	1585	I
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide)	7048	I
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)	7118	I
3,4-Methylenedioxymethamphetamine	7405	I
5-Methoxy-N-N-dimethyltryptamine	7431	I
Alpha-methyltryptamine	7432	I
N-Benzylpiperazine	7493	I
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine)	7509	I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)	7536	I
alpha-pyrrolidinopentiophenone (α-PVP)	7545	I
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))	9551	I
Secobarbital	2315	II
Fentanyl	9801	II

The company plans to synthesize the above controlled substances for distribution to its research and forensic customers.

Dated: September 23, 2019.

Thomas W. Prevoznik,

Acting Assistant Administrator, Deputy Assistant Administrator.